The Food and Drug Administration (FDA) has approved Likmez™, a ready-to-use liquid suspension formulation of metronidazole.
Likmez oral suspension is supplied in a 200mL bottle containing 500mg/5mL of metronidazole in a strawberry peppermint flavor. The product does not require refrigeration. Tetracaine Hcl Supplier
Likmez is indicated for the treatment of:
“Difficulty swallowing tablets and capsules should not be a barrier to accessing appropriate antibiotic therapy,” said Don Cilla, PharmD, MBA, Appili’s President and CEO. “Likmez provides a convenient alternative for patients who have difficulty taking solid oral medicines.”
Appili Therapeutics announces US FDA approval of Likmez™ (ATI-1501) Metronidazole Oral Suspension. News release. Appili Therapeutics. September 25, 2023. Accessed September 26, 2023. https://www.businesswire.com/news/home/20230925938803/en/Appili-Therapeutics-Announces-U.S.-FDA-Approval-of-LIKMEZ%E2%84%A2-ATI-1501-Metronidazole-Oral-Suspension .
Latest News Your top articles for Thursday
Haymarket Medical Network Top Picks
Continuing Medical Education (CME/CE) Courses
Please login or register first to view this content.
Larocaine Copyright © 2023 Haymarket Media, Inc. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions.